Invega trinza dosing

Initiate INVEGA TRINZA when the next 1-month paliperidone palmitate dose is scheduled with an INVEGA TRINZA dose based on the previous 1-month injection dose as shown below. (2.2) INVEGA TRINZA Doses for Adult Patients Adequately Treated with INVEGA SUSTENNA If the Last Dose of INVEGA SUSTENNA is: Initiate INVEGA TRINZA at

3.5-fold higher dose as shown in Table 1. INVEGA TRINZA may be administered up to 7 days before or after the monthly time point of the next scheduled paliperidone palmitate 1-month dose. Table 1. INVEGA TRINZA Doses for Adult Patients Adequately Treated with INVEGA SUSTENNA If the Last Dose of INVEGA SUSTENNA is: Initiate INVEGA TRINZA at the

For switching from INVEGA TRINZA to INVEGA SUSTENNA, INVEGA SUSTENNA should be started 3 months after the last INVEGA TRINZA dose, using the equivalent 3.5-fold lower dose as shown in the table below.

Following the initial INVEGA TRINZA dose, INVEGA TRINZA should be administered every 3 months. If needed, dose adjustment can be made every 3 months in

Dosing based on the client's last dose of Invega Sustenna or Invega Trinza Invega Sustenna for at least 4 months, or one-time injection of Invega Trinza.

during a dosing interval for INVEGA TRINZA. If administering a strong If the Last Dose of. INVEGA SUSTENNA is: Initiate INVEGA TRINZA at the.

Following the initial dose, Invega Trinza / Trevicta should be doses of PP1M be the same dosage strength before starting Invega Trinza.

Dosing: Initiate INVEGA TRINZA when the next 1-month paliperidone palmitate dose is scheduled with an INVEGA TRINZA dose based on the previous 1-month injection dose, using the equivalent 3.5-fold higher dose (see Table: INVEGA TRINZA Doses for Adult Patients Adequately Treated with INVEGA SUSTENNA in the Full Prescribing Information).

the last two doses of INVEGA SUSTENNA be the same dosage strength before starting INVEGA TRINZA. Initiate INVEGA TRINZA when the next 1-month paliperidone palmitate dose is scheduled with an INVEGA TRINZA dose based on the previous 1-month injection dose, using the equivalent 3.5-fold higher dose as shown in Table 1.